# Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.

> **NCT00674245** · PHASE2,PHASE3 · COMPLETED · sponsor: **Southern Arizona VA Health Care System** · enrollment: 40 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** Pantoprazole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00674245
- **Lead sponsor:** Southern Arizona VA Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674245, "Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00674245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*